A Conversation With the Myeloma Experts: Making Sense of the Evolving Treatment Landscape

Download All
Get up to date on the latest strategies for managing newly diagnosed and relapsed/refractory multiple myeloma (R/R MM) with downloadable slides, an on-demand webcast, a downloadable clinical resource, and an expert commentary from a satellite symposium at ASH 2022.
Brian G.M. Durie, MD
Program Director
Shaji K. Kumar, MD
person default
Yi Lin, MD, PhD
Thomas G. Martin, MD
Philippe Moreau, MD
S. Vincent Rajkumar, MD
Jesus San-Miguel, MD, PhD

On-Demand Webcast

Watch this on-demand webcast from an ASH satellite symposium on applying recent clinical findings in myeloma, including considerations for smoldering myeloma, treatment decisions for newly diagnosed patients, and the latest data on therapy for relapsed/refractory disease.

Brian G.M. Durie, MD
Program Director
Shaji K. Kumar, MD person default Yi Lin, MD, PhD Thomas G. Martin, MD Philippe Moreau, MD S. Vincent Rajkumar, MD Jesus San-Miguel, MD, PhD
Physicians: maximum of 2.5 AMA PRA Category 1 Credits Released: January 24, 2023 Expired: January 23, 2024

Downloadable Slideset

Download these slides from a live symposium for an overview of considerations for risk assessment and treatment of smoldering myeloma therapy.

Jesus San-Miguel, MD, PhD Released: December 9, 2022

Download these slides from a live symposium for expert perspective on treatment considerations for patients with newly diagnosed MM.

Philippe Moreau, MD Released: December 9, 2022

Download these slides from a live symposium for an expert overview on current considerations for treatment of patients with multiple myeloma at first relapse.

Thomas G. Martin, MD S. Vincent Rajkumar, MD Released: December 29, 2022

Download these slides from a live symposium for a summary of current considerations for patients with relapsed/refractory myeloma who have received multiple previous lines of therapy.

Shaji K. Kumar, MD Thomas G. Martin, MD Released: December 9, 2022

Download these slides from a live symposium for an expert review of the potential treatment options for patients with R/R MM after previous BCMA-targeted therapy.

person default Yi Lin, MD, PhD S. Vincent Rajkumar, MD Released: December 9, 2022

Download this slideset based on content from the annual CCO/IMF satellite symposium at ASH on a new 2023 treatment algorithm for patients with multiple myeloma.

S. Vincent Rajkumar, MD Released: December 12, 2022
Provided by Clinical Care Options, LLC in partnership with the International Myeloma Foundation.

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

In partnership with the
Supported by educational grants from
Amgen
Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC
Karyopharm Therapeutics Inc.
Pfizer, Inc.
Regeneron Pharmaceuticals, Inc.
Takeda Pharmaceuticals U.S.A., Inc.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings